Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.004% atropine sulfate eye drops for delaying progression of low-grade juvenile myopia
ChiCTR2100051609Phase 2Not yet recruiting
- Sponsor
- Hebei Eye Hospital
- Start
- Oct 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myopia comparing Atropine treatment group with Placebo control group (2 arms). Primary endpoint: Spherical equivalent refraction. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2100051609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051609.